HEALTH● LOWSep 22 · Sep 22, 2026, 11:26 AM
Merck says FDA approved label update for PAH therapy Winrevair
Seeking Alpha Tech · north america
Merck announced that the FDA has approved a label update for its pulmonary arterial hypertension therapy, Winrevair. This is important for the medical community and patients using this treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h ago161 confirmed measles cases, one death reported in KozhikodeThe HinduHEALTH3h agoLongevity-first healthcare takes spotlight at Abu Dhabi Future Health SummitSouth China Morning PostHEALTH3h agoKenya’s Ebola cases test preparedness beyond NairobiAl Jazeera [en]HEALTH5h agoEven after explosive diarrhea outbreak Trump’s FDA looks to ease food requirementsThe Independent World